These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications. Plager DA; Leontovich AA; Henke SA; Davis MD; McEvoy MT; Sciallis GF; Pittelkow MR Exp Dermatol; 2007 Jan; 16(1):28-36. PubMed ID: 17181634 [TBL] [Abstract][Full Text] [Related]
47. Drug load in clinical trials: a neglected factor. Deckers CL; Hekster YA; Keyser A; Meinardi H; Renier WO Clin Pharmacol Ther; 1997 Dec; 62(6):592-5. PubMed ID: 9433387 [No Abstract] [Full Text] [Related]
48. Pharmaceutical relevance of drug transporter malfunctions. Lancaster CS; Sparreboom A Clin Pharmacol Ther; 2011 Apr; 89(4):471-4. PubMed ID: 21423235 [No Abstract] [Full Text] [Related]
49. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development. Rolan P; Atkinson AJ; Lesko LJ; ; Clin Pharmacol Ther; 2003 Apr; 73(4):284-91. PubMed ID: 12709718 [No Abstract] [Full Text] [Related]
50. [Administration of drugs through the skin]. Dahlerup J Sygeplejersken; 1985 Mar; 85(10):17. PubMed ID: 3849115 [No Abstract] [Full Text] [Related]
51. Sex dependent pharmacokinetics and bioequivalence--time for a change. Koren G J Popul Ther Clin Pharmacol; 2013; 20(3):e358-61. PubMed ID: 24214491 [TBL] [Abstract][Full Text] [Related]
52. [Clinical-pharmacological questions on drug metabolism from the viewpoint of a dermatologist]. Ippen H Arzneimittelforschung; 1969 May; 19(5):814-5. PubMed ID: 5819798 [No Abstract] [Full Text] [Related]
53. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Peck CC; Barr WH; Benet LZ; Collins J; Desjardins RE; Furst DE; Harter JG; Levy G; Ludden T; Rodman JH J Pharm Sci; 1992 Jun; 81(6):605-10. PubMed ID: 1355792 [No Abstract] [Full Text] [Related]
54. Premarketing observational studies of population pharmacokinetics of new drugs. Sheiner LB; Benet LZ Clin Pharmacol Ther; 1985 Nov; 38(5):481-7. PubMed ID: 3931953 [No Abstract] [Full Text] [Related]
55. Therapeutic drug monitoring. Vozeh S Clin Pharmacol Ther; 1988 Dec; 44(6):713-4. PubMed ID: 3197369 [No Abstract] [Full Text] [Related]
56. Applications of photoacoustic spectroscopy to problems in dermatology research. Campbell SD; Yee SS; Afromowitz MA IEEE Trans Biomed Eng; 1979 Apr; 26(4):220-7. PubMed ID: 437803 [No Abstract] [Full Text] [Related]
57. Age-related changes in drug concentration in skin and lungs of mice. Ohkoshi M; Oka T J Dermatol; 1984 Oct; 11(5):438-42. PubMed ID: 6085086 [No Abstract] [Full Text] [Related]
58. Properties of suction de-epithelialized skin relative to drug delivery. Svedman P; Lundin S Acta Pharm Nord; 1992; 4(2):115-6. PubMed ID: 1388755 [No Abstract] [Full Text] [Related]
59. Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studies. Beger RD Expert Rev Mol Diagn; 2007 Mar; 7(2):113-5. PubMed ID: 17331060 [No Abstract] [Full Text] [Related]
60. [Pharmacodynamics biomarkers: application and considerations in clinical development]. Mito S; Sakai M; Suzuki M Nihon Yakurigaku Zasshi; 2016; 148(6):302-304. PubMed ID: 27904008 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]